We are live on ! Find out more
SABSW icon

SAB Biotherapeutics Warrant
SABSW

17 hedge funds and large institutions have $2.75M invested in SAB Biotherapeutics Warrant in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+17
Holders Change %
–
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
+$260K
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$260K
3
SCM
Shaolin Capital Management
Florida
+$249K
4
FTCM
Fir Tree Capital Management
New York
+$234K
5
RCM
Radcliffe Capital Management
Pennsylvania
+$182K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.72M +$182K +175,000 New
PC
2
Periscope Capital
Ontario, Canada
$158K +$260K +250,000 New
PAMP
3
Polar Asset Management Partners
Ontario, Canada
$150K +$260K +250,000 New
SCM
4
Shaolin Capital Management
Florida
$144K +$249K +239,227 New
FTCM
5
Fir Tree Capital Management
New York
$135K +$234K +225,000 New
PMAM
6
Picton Mahoney Asset Management
Ontario, Canada
$90K +$156K +150,000 New
ICM
7
Ionic Capital Management
New York
$86K +$148K +142,908 New
UOC
8
UBS O'Connor
Illinois
$83K +$130K +124,996 New
BCM
9
Basso Capital Management
Connecticut
$55K +$94.9K +91,370 New
RCM
10
Rivernorth Capital Management
Florida
$30K +$51.9K +49,998 New
AA
11
AQR Arbitrage
Connecticut
$30K +$51.9K +50,000 New
WAM
12
Wolverine Asset Management
Illinois
$28K +$48.9K +47,064 New
HF
13
HRT Financial
New York
$12K +$21.9K +21,060 New
Citadel Advisors
14
Citadel Advisors
Florida
$11K +$19.7K +18,955 New
EAM
15
Exos Asset Management
New York
$8K +$13K +12,500 New
PAM
16
Panagora Asset Management
Massachusetts
$5K +$7.79K +7,501 New
UBS Group
17
UBS Group
Switzerland
$2K +$3.67K +3,529 New

SABSW Hedge Fund Activity: Q1 2021 in Review

17 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in SAB Biotherapeutics Warrant (SABSW) for Q1 2021, worth a combined $2.75M.

Buyers outnumbered sellers: 17 funds opened new SABSW positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Periscope Capital, opening a new position worth an estimated $260K.

  • 17 institutional investors held SAB Biotherapeutics Warrant (SABSW) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $2.75M of SAB Biotherapeutics Warrant stock for Q1 2021.
  • 17 funds opened new SAB Biotherapeutics Warrant positions in Q1 2021 and 0 closed out, a net change of +17 holders.
  • The largest SAB Biotherapeutics Warrant buyer in Q1 2021 was Periscope Capital, an estimated $260K added.

Based on aggregated 13F filings for Q1 2021.